NEW YORK, April 25, 2018 /PRNewswire/ -- Global Sales of Stromal Vascular Fraction Therapies to Surpass US$ 101 Mn by 2025 End; South Korea Poised to Emerge Most Lucrative Prevalence of knee osteoarthritis is expected to provide a significant opportunity to the new class cell...
from PR Newswire: //https://ift.tt/2Ker3nu
No comments:
Post a Comment